Sign up now and fund within 24h to get free NKE, GPRO or DBX stock. T&Cs apply.
Redeem Now
AbbVie Inc

Kickstart your portfolio with a U.S. stock on us

Sign up and fund a new Wall St account and get a full U.S. share.T&Cs apply

Claim now
Kickstart your portfolio with a U.S. stock on us

About ABBV

AbbVie Inc. is a global, diversified, research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Duodopa is a levodopa-carbidopa intestinal gel for the treatment of Parkinson's disease. Eye care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella.

Market Capitalisation

$381.10B

Price-earnings ratio

-

Dividend yield

3.23%

Volume

5.41M

High today

$220.01

Low today

$215.70

Open price

$217.00

52-week high

$244.81

52-week low

$180.25

Ready to start your investing journey with Stake?

Open an account
Buying ABBV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in AbbVie Inc in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in ABBV

The ticker symbol for AbbVie Inc is ABBV.

One share of ABBV is valued at $216.74 as of 23 May 2026.

As of 23 May 2026 AbbVie Inc has a market cap of $381.10B.

Yes, ABBV does pay dividends.

The dividend yield for ABBV is 3.23% as of 23 May 2026.

The Price to Earnings ratio of ABBV is 105.86.

The Earnings Per Share of ABBV is $2.03.

The AbbVie Inc 52-week high stock price is $244.81.

The AbbVie Inc 52-week low stock price is $180.25.

Yes, the Stake investing platform allows you to buy ABBV shares and over 9,500 more stocks and ETFs on Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Stake app

Invest in ABBV on Stake

  • Buy ABBV from US$3 brokerage
  • Invest in 9,500+ U.S. stocks and ETFs
  • Own a slice of ABBV from only US$10 with fractional shares
Get started

Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.

ABBV related stocks

Footer


Made in Australia

Sydney, Australia

Subscribe to our newsletter

By subscribing, you agree to our Privacy Policy.



Get the app

Scan QR code to download the app

Stakeshop Pty Ltd is registered as an overseas company in New Zealand (NZBN: 9429047452152), and is registered as a Financial Service Provider under the Financial Service Providers (Registration and Dispute Resolution) Act 2008 (No. FSP774414). We hold a full licence issued by the Financial Markets Authority to provide a financial advice service under the Financial Markets Conduct Act 2013. However, the content on this website has not been prepared to take into account any of your individual objectives, financial situation or needs. To the extent you require further information about the relevant New Zealand legislation that may apply, or require specific advice, please contact your legal and/or financial adviser (as appropriate). The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Terms & Conditions, Privacy Policy, Financial Advice Disclosure and Disclaimers before deciding to use or invest on Stake. By using the Stake website or service in any way, you agree to our Privacy Policy and Terms & Conditions All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake is a registered trademark under class 36 (New Zealand).

Copyright © 2026 Stake. All rights reserved.